多西紫杉醇是新一代紫杉类化疗药物,具有抗癌活性高、疗效确切、毒性反应可耐受,成为乳腺癌治疗中最重要的化疗药物之一,我院2002年1月至2004年6月采用国产多西紫杉醇联合顺铂化疗转移性乳腺癌32例,将结果报告如下。1临床资料1·1一般资料:32例女性转移性乳腺癌,年龄32~71岁,中 Docetaxel is a new generation of taxane chemotherapy drugs, with high anticancer activity, the exact effect, toxicity can be tolerated, becoming the most important chemotherapy in breast cancer treatment of drugs, our hospital from January 2002 to 2004 6 Month using domestic docetaxel combined with cisplatin chemotherapy in 32 cases of metastatic breast cancer, the results reported below. 1 Clinical data 1.1 General Information: 32 cases of female metastatic breast cancer, aged 32 to 71 years, medium